Nov 23, 20212 minDragonfly Therapeutics Announces Merck Opt-In of TriNKET™ Immunotherapy Candidate for Patients
Nov 9, 20213 minDragonfly Announces DF1001 Granted Orphan Drug Designation in the US for Esophageal Cancer
Oct 18, 20212 minDragonfly Therapeutics Announces Sixth Dragonfly Drug to be Licensed by Bristol Myers Squibb
Jan 12, 20212 minDragonfly Therapeutics Announces AbbVie Opt-In of TriNKET™ Immunotherapy Drug Candidate